Cero Therapeutics Holdings, Inc.
CEROW- Exchange
- OTC
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001870404
No open-market purchases or sales by Cero Therapeutics Holdings, Inc. insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $4 in total; no superinvestor holds it.
Other share classesCERO
13F holders, Q1 2025
Institutional positions in Cero Therapeutics Holdings, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 26
- −1 vs. Q4 2024
- Shares held
- 3.33M
- +182.7K (+5.8%) vs. Q4 2024
- Total value
- $45.7K
- +$17.1K (+59.7%) vs. Q4 2024
- New holders
- 2
- 0 more added
- Sold out
- 3
- 3 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CEROW on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $4 |
| Q1 2026 | 1 | $11 |
| Q4 2025 | 1 | $22 |
| Q3 2025 | 22 | $38.1K |
| Q2 2025 | 23 | $74.5K |
| Q1 2025 | 26 | $45.7K |
| Q4 2024 | 27 | $28.6K |
| Q3 2024 | 31 | $28.0K |
| Q2 2024 | 35 | $110.3K |
| Q1 2024 | 38 | $425.3K |
| Q4 2023 | 41 | $135.1K |
| Q3 2023 | 44 | $423.7K |
| Q2 2023 | 44 | $351.0K |
| Q1 2023 | 47 | $234.9K |
| Q4 2022 | 50 | $264.8K |
| Q3 2022 | 44 | $503.0K |
| Q2 2022 | 42 | $550.0K |
| Q1 2022 | 36 | $1.02M |
| Q4 2021 | 31 | $1.35M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding Cero Therapeutics Holdings, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 2,500 | $36 | 0.00% | 00.0% | Unchanged |
| DuPont Capital Management Corp | 12,500 | $166 | 0.00% | 00.0% | Unchanged |
| Calamos Advisors LLC | 12,500 | $166 | 0.00% | 00.0% | Unchanged |
| Silver Rock Financial LP | 12,224 | $177 | 0.00% | 00.0% | Unchanged |
| Walleye Trading LLC | 13,333 | $193 | 0.00% | −57,020−81.0% | Reduced |
| Schonfeld Strategic Advisors LLC | 15,000 | $217 | 0.00% | 00.0% | Unchanged |
| Whitebox Advisors LLC | 23,250 | $337 | 0.00% | −1,750−7.0% | Reduced |
| Rivernorth Capital Management, LLC | 24,998 | $362 | 0.00% | 00.0% | Unchanged |
| Wolverine Asset Management LLC | 43,796 | $635 | 0.00% | 00.0% | Unchanged |
| Tenor Capital Management Co., L.P. | 50,000 | $725 | 0.00% | 00.0% | Unchanged |
| Yakira Capital Management, Inc. | 49,999 | $725 | 0.00% | 00.0% | Unchanged |
| Parallel Advisors, LLC | 50,000 | $725 | 0.00% | +50,000 | New |
| Westchester Capital Management, LLC | 74,998 | $937 | 0.00% | 00.0% | Unchanged |
| Picton Mahoney Asset Management | 75,000 | $1.00K | 0.00% | 00.0% | Unchanged |
| Highland Capital Management Fund Advisors, L.P. | 108,741 | $1.58K | 0.00% | 00.0% | Unchanged |
| Context Capital Management, LLC | 122,013 | $1.77K | 0.00% | 00.0% | Unchanged |
| Q Global Advisors, LLC | 170,785 | $2.00K | 0.00% | 00.0% | Unchanged |
| Clear Street LLC | 144,425 | $2.09K | 0.00% | −800−0.6% | Reduced |
| Blue Owl Capital Holdings LP | 224,930 | $2.25K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 192,874 | $2.80K | 0.00% | +192,874 | New |
| Linden Advisors LP | 249,999 | $3.33K | 0.00% | 00.0% | Unchanged |
| Saba Capital Management, L.P. | 295,913 | $3.77K | 0.00% | 00.0% | Unchanged |
| Clear Street Derivatives LLC | 268,129 | $3.89K | 0.00% | 00.0% | Unchanged |
| Periscope Capital Inc. | 274,000 | $3.97K | 0.00% | 00.0% | Unchanged |
| MMCAP International Inc. SPC | 375,000 | $5.44K | 0.00% | 00.0% | Unchanged |
| Cantor Fitzgerald, L. P. | 441,048 | $6.39K | 0.00% | 00.0% | Unchanged |
| Highbridge Capital Management LLC | 0 | $0 | 0.00% | – | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −500−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −87−100.0% | Sold out |